India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

The product is the generic equivalent of Nizoral Shampoo, 2 per cent. The approval adds to Zydus’s growing pharmaceutical portfolio in the US market, where Ketoconazole shampoo generated annual ...

The proposed acquisition shall act as a platform to execute our global MedTech strategy and a natural extension for Zydus having a proven track record in life sciences and wellness segments ...

Zydus Lifesciences has entered exclusive negotiations ... The company will leverage its global presence in pharmaceuticals to launch its medtech play. “Because of our global footprint in ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

(Reuters) -India's Zydus Lifesciences (ZYDUSLIFE.NS) said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical (AMPLI.PA) for 256.8 million euros (nearly $280 million) as part of ...

Zydus Lifesciences Ltd. on Tuesday said it has entered into exclusive negotiations to acquire a majority stake in France-based Amplitude Surgical for €256.8 million. “The acquisition price ...

Zydus Lifesciences Limited on Tuesday announced that the company has entered into exclusive negotiations to acquire majority Amplitude Surgical. Purchase consideration amounts to €256.8mn for 85 ...

BMO Capital initiated coverage of Rocket Pharmaceuticals (RCKT) with an Outperform rating and $50 price target The gene therapy company has “two major differences from the typical gene therapy ...